The time to return-to-work in healthcare workers with COVID-19 treated with ensitrelvir, a novel oral inhibitor of 3C-like protease of SARS-CoV-2: An observational study utilizing pre-existing data from a single hospital. - Katsuta M; Kitazono M; Nagai N; Karibe H; Takahashi Y; Ariwa Y; Sonoyama T; Yamaguchi T (Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2025)